| Symbol |
Name |
Standardized Value |
|
IFNA1
|
interferon, alpha 1
|
2.745
|
|
IFNA2
|
interferon, alpha 2
|
2.692
|
|
IFNA17
|
interferon, alpha 17
|
2.675
|
|
IFNA16
|
interferon, alpha 16
|
2.674
|
|
IFNA21
|
interferon, alpha 21
|
2.674
|
|
IFNA8
|
interferon, alpha 8
|
2.674
|
|
IFNA14
|
interferon, alpha 14
|
2.673
|
|
IFNA10
|
interferon, alpha 10
|
2.673
|
|
IFNA7
|
interferon, alpha 7
|
2.673
|
|
IFNA6
|
interferon, alpha 6
|
2.672
|
|
IFNA5
|
interferon, alpha 5
|
2.671
|
|
IFNA13
|
interferon, alpha 13
|
2.671
|
|
IFNA4
|
interferon, alpha 4
|
2.669
|
|
TRIM21
|
tripartite motif containing 21
|
2.517
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
2.489
|
|
CD81
|
CD81 molecule
|
2.457
|
|
PRTN3
|
proteinase 3
|
2.444
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
2.43
|
|
CD5
|
CD5 molecule
|
2.277
|
|
IFNL3
|
interferon, lambda 3
|
2.254
|
|
MYOM2
|
myomesin 2
|
2.25
|
|
ALB
|
albumin
|
2.241
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
2.209
|
|
C3
|
complement component 3
|
2.199
|
|
CD4
|
CD4 molecule
|
2.167
|
|
CD19
|
CD19 molecule
|
2.161
|
|
LOC102723407
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8
|
2.137
|
|
CRP
|
C-reactive protein, pentraxin-related
|
2.126
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
2.106
|
|
CD27
|
CD27 molecule
|
2.102
|
|
MPO
|
myeloperoxidase
|
2.039
|
|
DUSP1
|
dual specificity phosphatase 1
|
1.995
|
|
TNF
|
tumor necrosis factor
|
1.984
|
|
MAG
|
myelin associated glycoprotein
|
1.975
|
|
CD8A
|
CD8a molecule
|
1.938
|
|
MYD88
|
myeloid differentiation primary response 88
|
1.936
|
|
B2M
|
beta-2-microglobulin
|
1.875
|
|
IFNG
|
interferon, gamma
|
1.874
|
|
IL6
|
interleukin 6
|
1.856
|
|
PLA2R1
|
phospholipase A2 receptor 1, 180kDa
|
1.849
|
|
FCRL4
|
Fc receptor-like 4
|
1.847
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
1.839
|
|
RO60
|
Ro60, Y RNA binding protein
|
1.838
|
|
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
|
1.801
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
1.8
|
|
F2
|
coagulation factor II (thrombin)
|
1.78
|
|
MME
|
membrane metallo-endopeptidase
|
1.75
|
|
SDC1
|
syndecan 1
|
1.747
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
1.728
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
1.718
|
|
HP
|
haptoglobin
|
1.713
|
|
IL10
|
interleukin 10
|
1.71
|
|
CFHR5
|
complement factor H-related 5
|
1.703
|
|
BCR
|
breakpoint cluster region
|
1.697
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
1.689
|
|
IL1B
|
interleukin 1, beta
|
1.682
|
|
CD38
|
CD38 molecule
|
1.68
|
|
IL2
|
interleukin 2
|
1.68
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
1.634
|
|
C4B
|
complement component 4B (Chido blood group)
|
1.621
|
|
CD22
|
CD22 molecule
|
1.615
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
1.608
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
1.604
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
1.597
|
|
TLR9
|
toll-like receptor 9
|
1.596
|
|
TNFRSF25
|
tumor necrosis factor receptor superfamily, member 25
|
1.587
|
|
TLR7
|
toll-like receptor 7
|
1.582
|
|
AICDA
|
activation-induced cytidine deaminase
|
1.582
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
1.574
|
|
CXCL9
|
chemokine (C-X-C motif) ligand 9
|
1.569
|
|
CFH
|
complement factor H
|
1.567
|
|
CD40LG
|
CD40 ligand
|
1.564
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
1.555
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
1.547
|
|
IL4
|
interleukin 4
|
1.539
|
|
ACE
|
angiotensin I converting enzyme
|
1.537
|
|
ENO1
|
enolase 1, (alpha)
|
1.533
|
|
CFP
|
complement factor properdin
|
1.53
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
1.523
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
1.52
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
1.514
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
1.512
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
1.512
|
|
CLDN1
|
claudin 1
|
1.51
|
|
CNOT11
|
CCR4-NOT transcription complex, subunit 11
|
1.51
|
|
CFB
|
complement factor B
|
1.495
|
|
FCRL5
|
Fc receptor-like 5
|
1.491
|
|
TG
|
thyroglobulin
|
1.488
|
|
IL17A
|
interleukin 17A
|
1.483
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
1.469
|
|
SPATA31A3
|
SPATA31 subfamily A, member 3
|
1.469
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
1.467
|
|
C1S
|
complement component 1, s subcomponent
|
1.457
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
1.455
|
|
IL1A
|
interleukin 1, alpha
|
1.452
|
|
TSLP
|
thymic stromal lymphopoietin
|
1.45
|
|
CLDN7
|
claudin 7
|
1.443
|
|
FOXP3
|
forkhead box P3
|
1.437
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
1.431
|
|
BPIFA2
|
BPI fold containing family A, member 2
|
1.431
|
|
FN1
|
fibronectin 1
|
1.428
|
|
CD86
|
CD86 molecule
|
1.427
|
|
VWF
|
von Willebrand factor
|
1.427
|
|
GPT2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2
|
1.426
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
1.402
|
|
EPO
|
erythropoietin
|
1.401
|
|
TLR3
|
toll-like receptor 3
|
1.4
|
|
APOL1
|
apolipoprotein L, 1
|
1.396
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
1.395
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
1.383
|
|
TGFB1
|
transforming growth factor, beta 1
|
1.379
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
1.379
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
1.378
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
1.378
|
|
CFHR1
|
complement factor H-related 1
|
1.365
|
|
DNAJB9
|
DnaJ (Hsp40) homolog, subfamily B, member 9
|
1.36
|
|
IL18
|
interleukin 18
|
1.357
|
|
ACTA1
|
actin, alpha 1, skeletal muscle
|
1.35
|
|
SPN
|
sialophorin
|
1.35
|
|
STAT4
|
signal transducer and activator of transcription 4
|
1.346
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
1.341
|
|
AFP
|
alpha-fetoprotein
|
1.338
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
1.33
|
|
IL5
|
interleukin 5
|
1.322
|
|
WDR11
|
WD repeat domain 11
|
1.319
|
|
CD68
|
CD68 molecule
|
1.309
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
1.309
|
|
CFHR3
|
complement factor H-related 3
|
1.302
|
|
RAPGEF1
|
Rap guanine nucleotide exchange factor (GEF) 1
|
1.291
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
1.291
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
1.282
|
|
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)
|
1.274
|
|
CLEC18A
|
C-type lectin domain family 18, member A
|
1.271
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
1.271
|
|
MALT1
|
MALT1 paracaspase
|
1.27
|
|
INS
|
insulin
|
1.267
|
|
OCLN
|
occludin
|
1.263
|
|
CD80
|
CD80 molecule
|
1.263
|
|
SCARB1
|
scavenger receptor class B, member 1
|
1.255
|
|
THBD
|
thrombomodulin
|
1.253
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
1.252
|
|
IL7
|
interleukin 7
|
1.25
|
|
PAX5
|
paired box 5
|
1.249
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
1.248
|
|
FAS
|
Fas cell surface death receptor
|
1.248
|
|
REN
|
renin
|
1.24
|
|
C1R
|
complement component 1, r subcomponent
|
1.239
|
|
NCAM1
|
neural cell adhesion molecule 1
|
1.239
|
|
C5AR1
|
complement component 5a receptor 1
|
1.233
|
|
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric)
|
1.233
|
|
TLR4
|
toll-like receptor 4
|
1.233
|
|
CKMT1B
|
creatine kinase, mitochondrial 1B
|
1.232
|
|
CKB
|
creatine kinase, brain
|
1.229
|
|
TBX21
|
T-box 21
|
1.229
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
1.228
|
|
CKM
|
creatine kinase, muscle
|
1.227
|
|
TPO
|
thyroid peroxidase
|
1.223
|
|
SNRNP70
|
small nuclear ribonucleoprotein 70kDa (U1)
|
1.223
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
1.216
|
|
CD69
|
CD69 molecule
|
1.212
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
1.212
|
|
TLR2
|
toll-like receptor 2
|
1.207
|
|
NOTCH4
|
notch 4
|
1.199
|
|
CARD11
|
caspase recruitment domain family, member 11
|
1.194
|
|
NLRP3
|
NLR family, pyrin domain containing 3
|
1.191
|
|
CD52
|
CD52 molecule
|
1.191
|
|
CFI
|
complement factor I
|
1.19
|
|
ITIH4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4
|
1.186
|
|
FCRLA
|
Fc receptor-like A
|
1.183
|
|
CR1
|
complement component (3b/4b) receptor 1 (Knops blood group)
|
1.181
|
|
DUSP5
|
dual specificity phosphatase 5
|
1.177
|
|
IL15
|
interleukin 15
|
1.175
|
|
CTTNBP2
|
cortactin binding protein 2
|
1.167
|
|
DGKE
|
diacylglycerol kinase, epsilon 64kDa
|
1.166
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
1.163
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
1.163
|
|
IGLL5
|
immunoglobulin lambda-like polypeptide 5
|
1.163
|
|
THSD7A
|
thrombospondin, type I, domain containing 7A
|
1.16
|
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2
|
1.154
|
|
MX1
|
MX dynamin-like GTPase 1
|
1.153
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
1.15
|
|
IRF5
|
interferon regulatory factor 5
|
1.141
|
|
CFHR2
|
complement factor H-related 2
|
1.14
|
|
OR5H15
|
olfactory receptor, family 5, subfamily H, member 15
|
1.137
|
|
SPTAN1
|
spectrin, alpha, non-erythrocytic 1
|
1.132
|
|
DNAL1
|
dynein, axonemal, light chain 1
|
1.127
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
1.127
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
1.126
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
1.119
|
|
CCND1
|
cyclin D1
|
1.111
|
|
FCRL3
|
Fc receptor-like 3
|
1.1
|
|
JAK2
|
Janus kinase 2
|
1.099
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
1.098
|
|
IL22
|
interleukin 22
|
1.095
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
1.095
|
|
IFNL1
|
interferon, lambda 1
|
1.083
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
1.08
|
|
CA6
|
carbonic anhydrase VI
|
1.079
|
|
TP53
|
tumor protein p53
|
1.077
|
|
THPO
|
thrombopoietin
|
1.076
|
|
FCAR
|
Fc fragment of IgA receptor
|
1.075
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
1.071
|
|
C5
|
complement component 5
|
1.067
|
|
CD28
|
CD28 molecule
|
1.065
|
|
TLR8
|
toll-like receptor 8
|
1.059
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
1.059
|
|
CST3
|
cystatin C
|
1.058
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
1.049
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
1.048
|
|
SIGLEC6
|
sialic acid binding Ig-like lectin 6
|
1.047
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
1.047
|
|
CDR2
|
cerebellar degeneration-related protein 2, 62kDa
|
1.042
|
|
HAMP
|
hepcidin antimicrobial peptide
|
1.038
|
|
CD72
|
CD72 molecule
|
1.034
|
|
UROD
|
uroporphyrinogen decarboxylase
|
1.034
|
|
IL13
|
interleukin 13
|
1.033
|
|
ASZ1
|
ankyrin repeat, SAM and basic leucine zipper domain containing 1
|
1.032
|
|
IL7R
|
interleukin 7 receptor
|
1.029
|
|
CD2
|
CD2 molecule
|
1.024
|
|
SEPSECS
|
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase
|
1.023
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
1.02
|
|
OR2G3
|
olfactory receptor, family 2, subfamily G, member 3
|
1.019
|
|
CD7
|
CD7 molecule
|
1.018
|
|
ICOS
|
inducible T-cell co-stimulator
|
1.018
|
|
PTH
|
parathyroid hormone
|
1.015
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
1.014
|
|
PLG
|
plasminogen
|
1.012
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
1.009
|
|
AGRN
|
agrin
|
1.006
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
1.005
|
|
APLP1
|
amyloid beta (A4) precursor-like protein 1
|
1.005
|
|
NPPB
|
natriuretic peptide B
|
1.005
|
|
MAVS
|
mitochondrial antiviral signaling protein
|
1.002
|
